← Evidence map

ArticleJournal of personalized medicine2021

A Bioinformatics Analysis Identifies the Telomerase Inhibitor MST-312 for Treating High-STMN1-Expressing Hepatocellular Carcinoma.

Szu-Jen Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

8 papers cite it

2021
2022
2023
2024
2025
this paperpooled itcites it
Full record →Abstract, authors, funding and every citing paper · PMID 33922244